 | Info
Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
 | Out-
side |
| | | | |
|
| | | | MRI News Service:
'Lantheus Medical Imaging, Inc.' | | | Result: Searchterm 'Lantheus Medical Imaging, Inc.' found in 10 news | | Result Pages | | More Results:  Database (3) |
|
|  |  | | | '''''Lantheus Medical Imaging, Inc. ('Lantheus') today announced the successful completion of its previously announced private offering (the 'Offering') of $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the 'New Notes'). The ...' | | Monday, 21 March 2011 by www.radiopharm.com |
|
| | | | | '''''Lantheus Medical Imaging, Inc. (the Company) announced today that it has completed its previously announced offer to exchange (the Exchange Offer) up to $250,000,000 in aggregate principal amount of its currently outstanding 9.750% Senior Notes due 2017 ...' | | | Thursday, 3 February 2011 by www.radiopharm.com | |
|
| | | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced a national contract with Novation for ABLAVAR® (gadofosveset trisodium) and DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, ...' | | | Friday, 21 January 2011 by www.businesswire.com | |
|
| | | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that on December 30, 2010 it commenced an exchange offer for eligible holders to exchange any and all of the company's outstanding unregistered 9.75% ...' | | | Friday, 31 December 2010 by www.radiopharm.com | |
|
| | | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR® (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent. ...' | | | Thursday, 14 October 2010 by www.radiopharm.com | |
|
| | | | | ''''' Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, supports the U.S. Food and Drug Administration's (FDA) announcement requiring safety-related label changes for all gadolinium-based contrast agents to highlight the rare ...' | | | Friday, 10 September 2010 by www.radiopharm.com | |
|
| | | | | ''''' Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that it has acquired the balance of the worldwide rights for gadofosveset trisodium, a unique, injectable magnetic resonance angiography (MRA) blood pool ...' | | | Monday, 12 July 2010 by www.radiopharm.com | |
|
| | | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the first national contract signed for ABLAVAR® with Amerinet, Inc., a leading national healthcare group purchasing organization. ABLAVAR® (gadofosveset ...' | | | Thursday, 3 June 2010 by www.businesswire.com | |
|
| | | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVARâ„¢ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known ...' | | | Wednesday, 20 January 2010 by www.radiopharm.com | |
|
| | | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that two oral presentations featuring gadofosveset trisodium, the first and only FDA approved blood pool contrast agent for magnetic resonance angiography (MRA), ...' | | | Thursday, 8 October 2009 by www.businesswire.com | |
|
| | | | | | | | Result Pages | | | |
|
|
Anybody can sympathise with the sufferings of a friend, but it requires a
very fine nature to sympathise with a friend's success.
- Oscar Wilde |
|
|
|
| |
 | Look
Ups |
| |
News
top
